CDIO MEXC RealStocks
Own real CDIO shares through MEXC's regulated brokerage partner.
Suitable for long-term holding.
- Own the actual shares
- Receive dividends and voting rights
- Buy fractional shares starting at $1
Last updated: 2026-11-12 15:07:20. Prices reflect the latest regular market data. Stock price data is sourced from Massive.
Cardio Diagnostics Holdings Inc. (CDIO) operates in the IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES sector and is listed on NASDAQ. The stock is currently priced at $1.98, with a market capitalization of $5.50M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.97 to $7.91. This page covers its latest market performance, valuation, price trends and company information.
$5.50M | |
$1.97 | |
$2.07 | |
$1.91 | |
$1.92 | |
5.36K | |
28.93K | |
-- | |
$7.91 | |
$0.97 | |
-- | |
-- |
Cardio Diagnostics Holdings Inc. (CDIO) is currently trading at $1.98 as of 2026-11-12 15:03:00, up 0.25% ($0.01) from the previous close of $1.92
During today's regular trading session, CDIO has traded between $1.91 and $2.07, with a trading volume of 5.36K shares. The current price is near the middle of today's range.
Over the past seven days, Cardio Diagnostics Holdings Inc. (CDIO) moved from $1.60 to $1.98, representing a gain of 23.44% ($0.38).
The stock traded between $1.59 and $2.07 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 15.06 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 14.5%
CDIO is currently trading at $1.98, placing it 14.5% of the way from its 52-week low of $0.97 to its 52-week high of $7.91. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Cardio Diagnostics Holdings Inc is a medical technology company focused on developing and commercializing epigenetics-based clinical tests for cardiovascular diseases and associated comorbidities by leveraging its Artificial Intelligence (AI)-driven Multi-Omics Engine. The company has developed two clinical products: Epi+Gen CHD and PrecisionCHD, epigenetics-based clinical blood tests capable of assessing risk for a coronary heart disease (CHD) event, including heart attacks. Additionally, its portfolio includes HeartRisk, a cardiovascular disease risk intelligence platform, and CardioInnovate360, a research-use-only solution launched to support the discovery, development, and validation of novel biopharmaceuticals for the assessment and management of cardiovascular diseases.
| Industry | IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES |
| Employees | 17 |
| Exchange | NASDAQ |
| Company Website |
View the latest dividend and stock split events for Cardio Diagnostics Holdings Inc.
Dividend | |
|---|---|
| Ex-Dividend Date | -- |
| Payment Date | -- |
| Dividend Per Share | -- |
Stock Split | |
|---|---|
| Split Date | -- |
| Split Ratio | -- |
Eligible investors can buy real shares of Cardio Diagnostics Holdings Inc. (CDIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Stock prices and market data on this page, including price changes and market status, are provided by Massive and other third-party news and data platforms. Market data may be delayed and may differ from prices on other platforms or the prices at which trades are executed on MEXC. MEXC does not guarantee the accuracy, completeness, or timeliness of third-party data. MEXC offers trading products related to CDIO, including Stocks, Tokenized Stocks, and Stock Futures.
The stock price information displayed on this page is provided for reference purposes only and may be delayed or differ from real-time market data. Prices, charts, and related metrics do not constitute investment advice and should not be relied upon for trading or investment decisions. MEXC is not responsible for any losses incurred based on the stock price information provided on this page. Please refer to official market sources or consult licensed financial professionals before making any investment decisions.
Estimate the value between CDIO shares and USD.
CDIO Shares to USD
1.00 CDIO shares = 1.975 USD
Calculations are estimates based on the latest available price and are for reference only.